CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Relapse of malignancy after allogeneic hematopoietic cell transplantation (allo-HCT) remains a therapeutic challenge. Blockade of the CTLA4 molecule can effectively augment antitumor immunity mediated by autologous effector T cells. We have assessed the safety and preliminary efficacy of a neutraliz...

詳細記述

保存先:
書誌詳細
主要な著者: Bashey, Asad, Medina, Bridget, Corringham, Sue, Pasek, Mildred, Carrier, Ewa, Vrooman, Linda, Lowy, Israel, Solomon, Scott R., Morris, Lawrence E., Holland, H. Kent, Mason, James R., Alyea, Edwin P., Soiffer, Robert J., Ball, Edward D.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2009
主題:
Transplantation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2644086/
https://ncbi.nlm.nih.gov/pubmed/18974373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-168468
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料